Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / COM
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
1.82M
-
Shares change
-
0
-
Total reported value, excl. options
-
$1.31M
-
Price
-
$0.72
Significant Holders of Equillium, Inc. - COM (EQ) as of Q4 2023
1 filings reported holding EQ - Equillium, Inc. - COM as of Q4 2023.
Equillium, Inc. - COM (EQ) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.82M shares
.
Largest 10 shareholders include Decheng Capital LLC (4.45M shares), TAKEDA PHARMACEUTICAL CO LTD (1.82M shares), VANGUARD GROUP INC (837K shares), Cota Capital Management, LLC (562K shares), TANG CAPITAL MANAGEMENT LLC (400K shares), JPMORGAN CHASE & CO (350K shares), RENAISSANCE TECHNOLOGIES LLC (348K shares), GEODE CAPITAL MANAGEMENT, LLC (172K shares), COMMONWEALTH EQUITY SERVICES, LLC (100K shares), and Callan Capital, LLC (99.7K shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.